m+Medelevator.RU
← Поиск публикаций
Frontiers in neuroscience · 2025

APOE4-APP interactions exert early influences on cerebrovascular structure and function: implications for Alzheimer's disease.

СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Guo Lanboling, Gaunt Jessica R, Cheah Calvin Chee Hoe, Chen Albert I, Claudine Stephanie, Dawe Gavin S, Goh Eyleen Lay Keow, Kho Sok-Hong, Kumar Pawan, Lim Grace G Y, Lim Kah Leong, Lim Yun-An, Saido Takaomi C, Saito Takashi, Sasaguri Hiroki, Sng Judy C G, Yeap Yee Jie, Yip Alaric K K, Zainolabidin Norliyana, Ch'ng Toh Hean, Augustine George J

Аннотация

BACKGROUND: APOE4 and APP are two of the main genetic risk factors for Alzheimer's disease (AD). Although there have been suggestions that these two factors interact, most of the in vivo evidence for such interactions comes from transgenic mouse models that suffer from complications associated with protein overexpression. Our goal was to examine the consequences of interactions between APOE4 and APP on brain function while avoiding the use of transgenic mice.

METHODS: We generated and characterized double-mutant knock-in mice incorporating familial APP mutations and humanized APOE4.

RESULTS: In the brains of 3-month-old double-mutant mice there were significant alterations in vascular remodeling genes, vascular structure and blood-brain barrier permeability. These changes were not observed in either APOE4 or APP single-mutant mice and, thus, were caused by interactions between the two genes. These interaction effects were transient, because they were absent in 8-month-old double-mutant mice.

CONCLUSION: These findings indicate that early vascular changes, driven by the interaction of APP and APOE4, may influence the progression of AD. Our work highlights the need to focus on the synergistic vascular actions of APOE4 and APP, particularly at younger ages.

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты